ellipticine has been researched along with Endotoxin Shock in 2 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although inflammation has been clearly identified as a key factor in the onset and progression of cancer, the relationship between ellipticine and inflammation remains unknown." | 1.56 | Ellipticine Conveys Protective Effects to Lipopolysaccharide-Activated Macrophages by Targeting the JNK/AP-1 Signaling Pathway. ( Li, XY; Liang, HP; Luo, L; Ma, W; Ma, XY; Tang, WQ; Tang, X; Tian, LX; Xu, X; Yan, J; Yang, X; Yu, J; Zhou, XY, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q | 1 |
| Liu, J | 1 |
| Zhuang, Y | 1 |
| Bai, LP | 1 |
| Yuan, Q | 1 |
| Zheng, S | 1 |
| Liao, K | 1 |
| Khan, MA | 1 |
| Wu, Q | 1 |
| Luo, C | 1 |
| Liu, L | 1 |
| Wang, H | 1 |
| Li, T | 1 |
| Tian, LX | 1 |
| Li, XY | 1 |
| Tang, X | 1 |
| Zhou, XY | 1 |
| Luo, L | 1 |
| Ma, XY | 1 |
| Tang, WQ | 1 |
| Yu, J | 1 |
| Ma, W | 1 |
| Yang, X | 1 |
| Yan, J | 1 |
| Xu, X | 1 |
| Liang, HP | 1 |
2 other studies available for ellipticine and Endotoxin Shock
| Article | Year |
|---|---|
Identification of an IKKβ inhibitor for inhibition of inflammation in vivo and in vitro.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Drug Discovery; Ellipticines; Female; Humans; I- | 2019 |
Ellipticine Conveys Protective Effects to Lipopolysaccharide-Activated Macrophages by Targeting the JNK/AP-1 Signaling Pathway.
Topics: Adult; Animals; Anti-Inflammatory Agents; Cell Proliferation; Disease Models, Animal; Ellipticines; | 2020 |